Nanomolar β-glucosidase and β-galactosidase inhibition by enantiomeric α-1- C -alkyl-1,4-dideoxy-1,4-imino-arabinitol derivatives

Dong Zi,Ying-Ying Song,Tian-Tian Lu,Maki Kise,Atsushi Kato,Jun-Zhe Wang,Yue-Mei Jia,Yi-Xian Li,Chu-Yi Yu,George W.J. Fleet
DOI: https://doi.org/10.1016/j.ejmech.2022.115056
IF: 7.088
2022-12-29
European Journal of Medicinal Chemistry
Abstract:A series of α-1- C -alkyl DAB (1,4-dideoxy-1,4-imino- d -arabinitol) and LAB (1,4-dideoxy-1,4-imino- l -arabinitol) derivatives with aryl substituents have been designed as analogues of broussonetine W ( 12 ), and assayed as glycosidase inhibitors. While the inhibition spectrum of α-1- C -alkyl DAB derivative 16 showed a good correlation to that of broussonetine W ( 12 ), introduction of substituents on the terminal aryl ( 17a-f ) or hydroxyl groups at C-1′ position of the alkyl chains ( 18a-e ) decreased their α-glucosidase inhibitions but greatly improved their inhibitions of bovine liver β-glucosidase and β-galactosidase. Furthermore, epimerization of C-1′ configurations of compounds 18a-e clearly lowered their inhibition potency of bovine liver β-glucosidase and β-galactosidase. Notably, some of the α-1- C -alkyl DAB derivatives were also found to have potent human lysosome β-glucosidase inhibitions. In contrast, enantiomers of compounds 18a-e and 1′- epi -18a-e generally showed increased α-glucosidase inhibitions, but sharply decreased bovine liver β-glucosidase and β-galactosidase inhibitions. Molecular docking calculations unveiled the novel two set of binding modes for each series of compounds; introduction of C-1′ hydroxyl altered the conformations of the pyrrolidine rings and orientation of their long chains, resulting in improved accommodation in the hydrophobic grooves. The compounds reported herein are very potent β-glucosidase and β-galactosidase inhibitions with novel binding mode; and the structure-activity relationship provides guidance for design and development of more pyrrolidine pharmacological chaperones for lysosomal storage diseases.
chemistry, medicinal
What problem does this paper attempt to address?